Answers are grounded in this paper and cite their sources.
Introduction : Hip fractures in the elderly are a critical health challenge with high morbidity and mortality. Current guidelines advise early surgery, ideally within 24–48 hours, to reduce fatal complications. However, surgical delays remain common, with instances of preoperative peri-fracture fever or elevations in conventional inflammatory markers. Distinguishing between a sterile systemic inflammatory response to trauma and subclinical bacterial infection poses a diagnostic dilemma. Aim and Objectives : This systematic review evaluates the utility of procalcitonin (PCT) compared to conventional inflammatory markers (C-reactive protein, erythrocyte sedimentation rate, and leukocyte indices) in guiding surgical timing and optimizing perioperative decision-making for geriatric hip fracture patients. Materials and Methods : Following PRISMA 2020 guidelines, a systematic search of PubMed/MEDLINE was executed through December 2025. Studies evaluating PCT and conventional inflammatory markers in orthopedic settings relevant to geriatric hip fractures were analyzed through narrative synthesis. Results : Preoperative fever is rare in hip fractures. Conventional markers like CRP exhibit predictable, significant, yet highly nonspecific elevations due to physiological response to tissue injury and hematoma formation, peaking at 48–72 hours regardless of infectious status. Procalcitonin demonstrates no utility as a universal screening tool at the time of initial trauma admission. However, in the perioperative phase, selective utilization of PCT—utilizing thresholds of 0.25–0.5 ng/mL—provides superior specificity over CRP in distinguishing true bacterial sepsis from sterile surgical/traumatic inflammation. Conclusion : The routine use of procalcitonin in hip fracture pathways is not supported by current evidence. Its application should be strictly reserved in highly suspect cases. Surgical intervention must not be delayed solely on the basis of isolated, non-specific laboratory abnormalities, as the systemic risks of immobility far outweigh the theoretical risks of operating in the presence of sterile inflammation.
No takes yet. Share an insight, caveat, or question.
Aachi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: